Clinical Trial Update: Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing once-daily tigecycline to the standard regimen for multidrug-resistant infections is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-resistant Infections
• Infectious Diseases

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Air Force Specialized Hospital, Cairo, Egypt | Conditions: Multi Drug Resistant Infections | Phase 4 | Status: ACTIVE_NOT_RECRUITING